Exclusive: Russian site says it has brokered authorships for more than 10,000 researchers

Want to be a first author on a scholarly paper? A Russian company has you covered — starting at about $500. The company claims to have added the names of more than 10,000 researchers to more than 2,000 published articles in scholarly journals over the past three years. Think eBay — or perhaps StubHub — for unscrupulous scientists. 

Although we can’t verify the numbers, at least one major journal indexer, from whom we recently learned of the scheme, is concerned enough about the site that it has demanded that it stop doing business. 

According to the Russian outfit’s site (through Google Translate): 

Continue reading Exclusive: Russian site says it has brokered authorships for more than 10,000 researchers

Exclusive: St. Jude Children’s suspends enrollment in cancer trials over toxicity concerns

st judesSt. Jude Children’s Research Hospital in Memphis has temporarily halted enrollment in six bone marrow transplant trials due to concerns over how side effects were being identified in medical records, Retraction Watch has learned.

According to a source familiar with the trials, five of the six being suspended were all enrolling children with blood cancers who lacked a matching donor. During the trials, doctors took bone marrow from a parent — not a perfect match — and manipulated the cells before transplant to make them more capable of killing cancer, and less likely to be rejected.

Four trials, a few of which were scheduled to enroll more than 100 children, are being led by Brandon Triplett. Two are led by Mari Dallas, according to the source. Genzyme and the U.S. National Cancer Institute are listed as collaborators. Both Dallas and Triplett work under bone marrow transplant department chair Wing Leung.

We reached out to Scientific and Comprehensive Cancer Center Director Richard Gilbertson, who referred us to PR firm Rubenstein Public Relations. They sent us the following statement: Continue reading Exclusive: St. Jude Children’s suspends enrollment in cancer trials over toxicity concerns

Exclusive: Former NIH lab head who faked data now working as government patent examiner

usptoThe former director  of the X-ray crystallography lab at the National Institute of Arthritis and Musculoskeletal and Skin Diseases, part of the National Institutes of Health, who was found by the Office of Research Integrity to have faked findings in three papers, is once again earning a government salary, this time as a patent examiner, Retraction Watch has learned. Continue reading Exclusive: Former NIH lab head who faked data now working as government patent examiner

So who bought ScienceBlogs? Retraction Watch exclusive: National Geographic

This afternoon, PZ Myers, of the wildly popular Pharyngula blog on ScienceBlogs, started a post with a few lines that set science writers on Twitter abuzz:

I have news. Scienceblogs is going to be folded into a new organization sometime soon — basically, we’ve been bought. I can’t discuss all of the details just yet, but let’s just say it is a prestigious national magazine with a healthy bottom line that will do us a lot of good.

Retraction Watch has learned, from a source familiar with the negotiations, that the buyer is National Geographic. We don’t have any details at this point, and Nat Geo has not returned a request for comment [see update at end], but we are confident in reporting this.

Readers may recall PepsiGate, Continue reading So who bought ScienceBlogs? Retraction Watch exclusive: National Geographic

Exclusive: UEL staff “in uproar about lack of progress” investigating Jatinder Ahluwalia

On Friday, we reported that the University of East London (UEL) was looking into the career of Jatinder Ahluwalia, the UEL researcher who has left a trail of alleged scientific misconduct at Cambridge University and University College London.

Today, in another Retraction Watch exclusive, we have obtained a letter sent by a faculty member at UEL to department colleagues. It suggests that faculty there are very concerned about the toll these allegations may take on the university’s students and reputation, and are furious that senior officials have failed to keep them in the loop about any potential investigation.

Here’s the text of the letter: Continue reading Exclusive: UEL staff “in uproar about lack of progress” investigating Jatinder Ahluwalia